CA50785-2 - 0x0000000000006BE2
Healthy Males & Females
Forward
* Stipend may pay up to reflected amount.
Start Date:
June 7, 2026 - 4:00pm
End Date:
June 15, 2026 - 10:30am
Study Details
Study Number: CA50785
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16
Study Schedule
Schedule Type: Short stays with returns
Study Length: 3 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 5/27/2026 |
| Thursday | 5/28/2026 |
| Monday | 6/1/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 5/27/2026 |
| Thursday | 5/28/2026 |
| Monday | 6/1/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Sunday | 6/7/2026 4:00:00 PM | Wednesday | 6/10/2026 10:30:00 AM | 1 | Lincoln |
| Return | Monday | 6/15/2026 9:30:00 AM | Monday | 6/15/2026 10:30:00 AM | 1 | Lincoln |
